Corient Private Wealth’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$317K Buy
+2,893
New +$322K ﹤0.01% 2733

Other funds holding PPH

Corient Private Wealth's PPH Position: Q3 2026 in Review

Corient Private Wealth opened a new position in VanEck Pharmaceutical ETF (PPH) in Q3 2026: 2,893 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #2733 among its holdings.

156 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • Corient Private Wealth held 2,893 shares of VanEck Pharmaceutical ETF worth $317K as of Q3 2026.
  • VanEck Pharmaceutical ETF was a new Corient Private Wealth position in Q3 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2733 holding.
  • 156 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.